{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:46:31Z","timestamp":1783608391631,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study was performed to detect risk factors for <jats:italic>Pseudomonas aeruginosa<\/jats:italic> bacteremia in patients with liver cirrhosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective case\u2013control study was designed to identify risk factors for <jats:italic>P<\/jats:italic>. <jats:italic>aeruginosa<\/jats:italic> bacteremia in cirrhotic patients. The cases were cirrhotic patients with <jats:italic>P<\/jats:italic>. <jats:italic>aeruginosa<\/jats:italic> bacteremia and the controls were cirrhotic patients with Enterobacteriaceae bacteremia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sixty-one cases and the same number of controls were enrolled. In a multivariate analysis, younger age {adjusted odds ratio (aOR) per one year: 0.96, 95% confidence interval: 0.93 - 0.99}, nosocomial acquisition (aOR 3.87, 95% confidence interval: 1.50 - 9.94), preexisting biliary disease (aOR 4.79, 95% confidence interval: 1.92 - 10.47), and recent exposure to immunosuppressive agent (aOR 3.10, 95% confidence interval: 1.23 - 7.82) were associated with <jats:italic>P<\/jats:italic>. <jats:italic>aeruginosa<\/jats:italic> bacteremia. In the case group the frequency of appropriate initial antibiotic regimens was considerably lower than in the control group: 29.5% vs. 65.6% (<jats:italic>P<\/jats:italic> &lt;0.01). However, thirty day mortality did not differ significantly between cases and controls (19.7% vs. 24.6%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Nosocomial acquisition, preexisting biliary disease, and recent use of immunosuppressive agents are strong predictive factors for <jats:italic>P<\/jats:italic>. <jats:italic>aeruginosa<\/jats:italic> bacteremia in cirrhotic patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-13-332","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T16:14:08Z","timestamp":1374250448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae"],"prefix":"10.1186","volume":"13","author":[{"given":"Ji Hwan","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinhye","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyeong Gyun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-don","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,19]]},"reference":[{"key":"2530_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fernandez","year":"2002","unstructured":"Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J: Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002, 35: 140-148. 10.1053\/jhep.2002.30082.","journal-title":"Hepatology"},{"key":"2530_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","volume":"124","author":"MG Foreman","year":"2003","unstructured":"Foreman MG, Mannino DM, Moss M: Cirrhosis as a risk factor for sepsis and death: analysis of the national hospital discharge survey. Chest. 2003, 124: 1016-1020. 10.1378\/chest.124.3.1016.","journal-title":"Chest"},{"key":"2530_CR3","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/hep.23264","volume":"50","author":"T Gustot","year":"2009","unstructured":"Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R: Severe sepsis in cirrhosis. Hepatology (Baltimore, Md). 2009, 50: 2022-2033. 10.1002\/hep.23264.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"2530_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1086\/317494","volume":"31","author":"AM Thulstrup","year":"2000","unstructured":"Thulstrup AM, Sorensen HT, Schonheyder HC, Moller JK, Tage-Jensen U: Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000, 31: 1357-1361. 10.1086\/317494.","journal-title":"Clin Infect Dis"},{"key":"2530_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1530-0277.2006.00074.x","volume":"30","author":"G Linderoth","year":"2006","unstructured":"Linderoth G, Jepsen P, Schonheyder HC, Johnsen SP, Sorensen HT: Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study. Alcohol Clin Exp Res. 2006, 30: 636-641. 10.1111\/j.1530-0277.2006.00074.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"2530_CR6","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1001\/archinte.1996.00440170139015","volume":"156","author":"F Vidal","year":"1996","unstructured":"Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, Gatell JM, Soriano E, Jimenez de Anta MT: Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. analysis of 189 episodes. Arch Intern Med. 1996, 156: 2121-2126. 10.1001\/archinte.1996.00440170139015.","journal-title":"Arch Intern Med"},{"key":"2530_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/377200","volume":"37","author":"CI Kang","year":"2003","unstructured":"Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW: Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003, 37: 745-751. 10.1086\/377200.","journal-title":"Clin Infect Dis"},{"key":"2530_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/clinids\/10.3.629","volume":"10","author":"J Bisbe","year":"1988","unstructured":"Bisbe J, Gatell JM, Puig J, Mallolas J, Martinez JA, Soriano E, Jimenez de Anta MT: Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis. 1988, 10: 629-635. 10.1093\/clinids\/10.3.629.","journal-title":"Rev Infect Dis"},{"key":"2530_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s100960050164","volume":"17","author":"A Kuikka","year":"1998","unstructured":"Kuikka A, Valtonen VV: Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis. 1998, 17: 701-708. 10.1007\/s100960050164.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2530_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1469-0691.1995.tb00455.x","volume":"1","author":"WR Gransden","year":"1995","unstructured":"Gransden WR, Leibovici L, Eykyn SJ, Pitlik SD, Samra Z, Konisberger H, Drucker M, Phillips I: Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. Clin Microbiol Infect. 1995, 1: 119-123. 10.1111\/j.1469-0691.1995.tb00455.x.","journal-title":"Clin Microbiol Infect"},{"key":"2530_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2011.06.011","volume":"63","author":"EJ Joo","year":"2011","unstructured":"Joo EJ, Kang CI, Ha YE, Kim J, Kang SJ, Park SY, Lee NY, Wi YM, Chung DR, Peck KR, Song JH: Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor. J Infect. 2011, 63: 207-214. 10.1016\/j.jinf.2011.06.011.","journal-title":"J Infect"},{"key":"2530_CR12","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s10096-008-0568-5","volume":"27","author":"HS Cheong","year":"2008","unstructured":"Cheong HS, Kang CI, Wi YM, Ko KS, Chung DR, Lee NY, Song JH, Peck KR: Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis. 2008, 27: 1219-1225. 10.1007\/s10096-008-0568-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2530_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/596709","volume":"48","author":"V Schechner","year":"2009","unstructured":"Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ, Carmeli Y: Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?. Clin Infect Dis. 2009, 48: 580-586. 10.1086\/596709.","journal-title":"Clin Infect Dis"},{"key":"2530_CR14","first-page":"2835","volume-title":"Principles and practice of infectious diseases. Volume 2","author":"GB Pier","year":"2010","unstructured":"Pier GB, Ramphal R: Pseudomonas aeruginosa. Principles and practice of infectious diseases. Volume 2. Edited by: Mandell GM, Bennett JE, Dolin R. 2010, Philadelphia, PA, the Unites States: Churchill Livingsone, 2835-2860. 7","edition":"7"},{"key":"2530_CR15","unstructured":"Vuotto F, Berthon C, Lemaitre N, Duhamel A, Balkaran S, Le Ray E, Micol JB, Faure K, Alfandari S: Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case\u2013control study. Am J Infect Control. in press"},{"key":"2530_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjmed.2008.03.034","volume":"121","author":"HS Cheong","year":"2008","unstructured":"Cheong HS, Kang CI, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR: Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med. 2008, 121: 709-714. 10.1016\/j.amjmed.2008.03.034.","journal-title":"Am J Med"},{"key":"2530_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/00365548.2012.730151","volume":"45","author":"CI Kang","year":"2013","unstructured":"Kang CI, Sung YK, Lee KH, Lee KT, Lee JK: Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections. Scand J Infect Dis. 2013, 45: 227-234. 10.3109\/00365548.2012.730151.","journal-title":"Scand J Infect Dis"},{"key":"2530_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s15010-012-0358-y","volume":"41","author":"W Kwon","year":"2013","unstructured":"Kwon W, Jang JY, Kim EC, Park JW, Han IW, Kang MJ, Kim SW: Changing trend in bile microbiology and antibiotic susceptibilities: over 12\u00a0years of experience. Infection. 2013, 41: 93-102. 10.1007\/s15010-012-0358-y.","journal-title":"Infection"},{"key":"2530_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/jac\/dks062","volume":"67","author":"M Ortega","year":"2012","unstructured":"Ortega M, Marco F, Soriano A, Almela M, Martinez JA, Lopez J, Pitart C, Mensa J: Epidemiology and prognostic determinants of bacteraemic biliary tract infection. J Antimicrob Chemother. 2012, 67: 1508-1513. 10.1093\/jac\/dks062.","journal-title":"J Antimicrob Chemother"},{"key":"2530_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1286-4579(00)01349-6","volume":"3","author":"N Hoiby","year":"2001","unstructured":"Hoiby N, Kharazmi A, Ciofu O, Song Z, Moser C, Krogh Johansen H: Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 2001, 3: 23-35. 10.1016\/S1286-4579(00)01349-6.","journal-title":"Microbes Infect"},{"key":"2530_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1574-6976.2011.00322.x","volume":"36","author":"EE Mann","year":"2012","unstructured":"Mann EE, Wozniak DJ: Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol Rev. 2012, 36: 893-916. 10.1111\/j.1574-6976.2011.00322.x.","journal-title":"FEMS Microbiol Rev"},{"key":"2530_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0002-9343(87)90153-7","volume":"82","author":"S Szabo","year":"1987","unstructured":"Szabo S, Mendelson MH, Mitty HA, Bruckner HW, Hirschman SZ: Infections associated with transhepatic biliary drainage devices. Am J Med. 1987, 82: 921-926. 10.1016\/0002-9343(87)90153-7.","journal-title":"Am J Med"},{"key":"2530_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0002-9343(93)90331-I","volume":"95","author":"MJ Struelens","year":"1993","unstructured":"Struelens MJ, Rost F, Deplano A, Maas A, Schwam V, Serruys E, Cremer M: Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med. 1993, 95: 489-498. 10.1016\/0002-9343(93)90331-I.","journal-title":"Am J Med"},{"key":"2530_CR24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5694\/j.1326-5377.1993.tb138046.x","volume":"159","author":"SC Chen","year":"1993","unstructured":"Chen SC, Lawrence RH, Byth K, Sorrell TC: Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?. The Medical journal of Australia. 1993, 159: 592-597.","journal-title":"The Medical journal of Australia"},{"key":"2530_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","volume":"49","author":"ST Micek","year":"2005","unstructured":"Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH: Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005, 49: 1306-1311. 10.1128\/AAC.49.4.1306-1311.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"2530_CR26","first-page":"383","volume":"50","author":"J Sifuentes-Osornio","year":"1998","unstructured":"Sifuentes-Osornio J, Gonzalez R, Ponce-de-Leon A, Guerrero ML: Epidemiology and prognosis of Pseudomonas aeruginosa bacteremia in a tertiary care center. Rev Invest Clin. 1998, 50: 383-388.","journal-title":"Rev Invest Clin"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-332\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:49:33Z","timestamp":1630543773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-332","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,19]]},"assertion":[{"value":"11 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"332"}}